Aripiprazole Lauroxil

75 interactions 5 explained in plain English

Also sold as: Aristada

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Metoclopramide Nasal Spray Metoclopramide Injection Ketoconazole Topical Morphine Injection Galantamine Oxaliplatin Injection

3 Contraindicated 71 Major 1 Moderate

All (75) Contraindicated (3) Major (71) Moderate (1)

Major

Aripiprazole Lauroxil Glasdegib Daurismo Increased risk of QT interval prolongation Details Aripiprazole Lauroxil Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Aripiprazole Lauroxil Granisetron Transdermal Patch Sancuso An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Granisetron Injection Granisol An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Aripiprazole Lauroxil Hydromorphone Injection Dilaudid Increased risk of respiratory and CNS depression Details Aripiprazole Lauroxil Hydromorphone Rectal available generically Increased risk of respiratory and CNS depression Details Aripiprazole Lauroxil Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Aripiprazole Lauroxil Ivabradine Corlanor An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Lacosamide Injection Motpoly An increased risk of CNS depression Details Aripiprazole Lauroxil Lefamulin Xenleta Increased risk of QT interval prolongation Details Aripiprazole Lauroxil Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Aripiprazole Lauroxil Levodopa Oral Inhalation Inbrija An increased risk of CNS depression Details Aripiprazole Lauroxil Levofloxacin Levaquin An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Levofloxacin Injection Levaquin An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Aripiprazole Lauroxil Mefloquine Lariam® An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Metronidazole Flagyl An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Midazolam Nasal Spray Nayzilam An increased risk of sedation and orthostatic hypotension Details Aripiprazole Lauroxil Midazolam Injection Nayzilam An increased risk of sedation and orthostatic hypotension Details Aripiprazole Lauroxil Morphine Injection Astramorph® PF Increased risk of profound sedation, respiratory depression, hypotension, coma and death Details Aripiprazole Lauroxil Moxifloxacin Avelox An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Moxifloxacin Injection Avelox An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Moxifloxacin Ophthalmic Moxeza® An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Octreotide Bynfezia An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Octreotide Injection Bynfezia An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Ofloxacin Floxin® An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Ofloxacin Ophthalmic Ocuflox An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Ofloxacin Otic Floxin® Otic An increased risk of QT interval prolongation Details Aripiprazole Lauroxil Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Aripiprazole Lauroxil Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Moderate

Aripiprazole Lauroxil Clonidine Transdermal Patch Catapres An increased risk of sedation and somnolence Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.